Guttate psoriasishttps://en.wikipedia.org/wiki/Guttate_psoriasis
Guttate psoriasis jẹ irú psoriasis tí ó ń hàn gẹ́gẹ́ bí àwọ̀n ọ̀gbẹ́ kékeré (0.5‑1.5 cm ní ìwọ̀n ìlà‑òpin) lórí ẹ̀yìn, orí àti àwọn àgbègbè tó súnmọ́; a máa ń rí i ní àgbàlagbà tó wà ní ọdún àtàwọn ọdọ. Ọ̀rọ̀ “guttate” ni a lò láti ṣàpèjúwe bí àwọ̀n ọ̀gbẹ́ ṣe ń hàn. Guttate psoriasis sábà máa ń wáyé lẹ́yìn àrùn kokoro, ní pàtàkì ikọlu àtọ́runwa.

Nọ́mbà àwọ̀n ọ̀gbẹ́ lè wà láàrin 5 sí ju 100. Ní gbogbogbo, àwọ̀n ara tó ń nípa jùlọ ni a máa rí lórí àpá, ẹsẹ̀, ẹ̀yìn àti torso.

Àwọn ìtọ́jú tí a máa ń lò fún psoriasis lè tún wúlò fún guttate psoriasis. Ìpò náà sábà máa ń parí ní àkókò tó wà láàrin ọ̀sẹ̀ sí oṣù, ó sì jẹ́ pé kìkì ìdá mẹ́ta (1/3) nínú àwọn aláìsàn ni yóò ní psoriasis tó ń gùn.

Itọju – Oògùn OTC
Ó máa ń parí lairotẹlẹ ní àkókò. Ó lè gba tó oṣù kan.
#OTC steroid ointment

Itọju
#Phototherapy
☆ AI Dermatology — Free Service
Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
  • Awọn egbo lori ẹhin torso. Ọ̀pọ̀lọpọ̀ àìlera kékeré, àwọn macules scaly tàbí àwọn abulẹ̀ ń ṣẹlẹ̀ lórí ẹ̀hìn mọ́tò lẹ́yìn ààmì àìsàn tó wọ́pọ̀. Nítorí pé ó ń bọ̀ sí i nígbà tí ó bá farahàn sí ìmọ́lẹ̀ oorùn, ó máa ń hàn ní àkọ́kọ́ lórí ẹ̀hìn mọ́tò.
    References Guttate Psoriasis 29494104 
    NIH
    Guttate psoriasis jẹ apẹrẹ alailẹgbẹ ti psoriasis ti a maa nfa nipasẹ awọn akoran streptococcal, gẹgẹ bi ọfun tabi awọn akoran perianal. O wọpọ julọ laarin awọn ọmọde ati awọn ọdọ ju awọn agbalagba lọ. Awọn eniyan ti o ni ipo yii maa n dagbasoke ọpọlọpọ awọn ọgbẹ kekere ti o ni irisi omi ti o tan kaakiri, ti o maa n pọ si pẹlu awọn ipara agbegbe ati itọju imole.
    Guttate psoriasis is a distinct variant of psoriasis that is classically triggered by streptococcal infection (pharyngitis or perianal) and is more common in children and adolescents than adults. Patients present with several, small “drop-like” lesions that respond well to topical and phototherapies.
     Childhood guttate psoriasis: an updated review 37908643 
    NIH
    Guttate psoriasis jẹ ipo ti o wọpọ ti o kan 0.5–2% awọn ọmọde. Ni igbagbogbo, o farahan lojiji pẹlu ọpọlọpọ awọn petele kekere, tuka, ti o dabi omije, scaly, pupa, awọn bumps nyún, ati awọn abulẹ, paapaa lori ẹhin ati awọn ẹsẹ. Nigba miiran, o ni asopọ pẹlu ikolu strep laipẹ kan. Lakoko ti o le yọ kuro funra rẹ laarin oṣu 3–4 laisi aleebu, o tun le pada wa, tuka, ati tan, tabi le tẹsiwaju ki o yipada si psoriasis plaque onibaje ninu 40–50% awọn iṣẹlẹ. Nítorí pé ó lè lọ fúnra rẹ, ìtọ́jú lè má ṣe pàtàkì nígbà gbogbo ayafi fún irisi tàbí nyún.
    Guttate psoriasis is common and affects 0.5–2% of individuals in the paediatric age group. Guttate psoriasis typically presents with an abrupt onset of numerous, small, scattered, tear-drop-shaped, scaly, erythematous, pruritic papules and plaques. Sites of predilection include the trunk and proximal extremities. There may be a history of preceding streptococcal infection. Koebner phenomenon is characteristic. Guttate psoriasis may spontaneously remit within 3–4 months with no residual scarring, may intermittently recur and, in 40–50% of cases, may persist and progress to chronic plaque psoriasis. Given the possibility for spontaneous remission within several months, active treatment may not be necessary except for cosmetic purposes or because of pruritus. On the other hand, given the high rates of persistence of guttate psoriasis and progression to chronic plaque psoriasis, some authors suggest active treatment of this condition.